Concepedia
Statistics
Publications
19
Citations
2K
H-Index
15
Active since
1997
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
University of Göttingen
Universitätsmedizin Göttingen
Max Planck Institute for Biophysical Chemistry
Raphael Koch is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
1997–2024
Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3
Thiha Aung, Bjoern Chapuy, Daniel Vogel et al. · Proceedings of the National Academy of Sciences · 2011 · 359 citations · Full text
Medicine, Cancer Biology, Oncology +17
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text
Medicine, Biomedical Sciences, Drug Discovery +6
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
Steven M. Horwitz, Raphael Koch, Pierluigi Porcu et al. · Blood · 2017 · 283 citations · Full text
Medicine, Oncology, Pharmacology +7
Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration
Bjoern Chapuy, Raphael Koch, Ulf K Radunski et al. · Leukemia · 2008 · 156 citations · Full text
Medicine, Cell Biology, Pharmacology +16
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
Yonghan He, Raphael Koch, Vivekananda Budamagunta et al. · Journal of Hematology & Oncology · 2020 · 131 citations · Full text
Medicine, Cancer Biology, Oncology +14
1–5 of 19